McKesson pays $1.46B for medical products distributor; NeuroMetrix revenue drops in Q3;

 @FierceMedDev: Alere warned by FDA for cardio Dx quality shortfalls. Item | Follow @FierceMedDev

 @MarkHFierce: A Senate report blasts Medtronic for improperly shaping data regarding its Infuse bone graft, all to boost sales. Story | Follow @MarkHFierce

 @DamianFierce: 2012 was less than a banner year for med device and diagnostic IPOs. We take a look at the numbers: Report | Follow @DamianFierce

> Drug wholesaler McKesson ($MCK) will buy medical products distributor PSS World Medical ($PSSI) for $1.46 billion in a bid to beef up its surgical devices supply business. Story

> NeuroMetrix ($NURO), a maker of devices that diagnose and treat neurological complications from diabetes, reported more than $1.7 million in revenue during its fiscal 2012 third quarter, down from over $2.5 million reported during the same period in 2011. Item

> Medical device-related mergers and acquisitions activity declined drastically in the 2012 third quarter, as part of a larger decline in the overall health care industry, according to Irving Levin Associates. Item

> Elixir Medical says it completed enrollment in a 120-patient pivotal trial testing its DESolve drug eluting bioresorbable coronary scaffold system--which should be resorbed back into the body within two years of implantation. Release

> Teleflex ($TFX) inked a two-year extension of a deal with Novation for it to keep offering a line of laryngoscopes and related accessories. Release

> The U.K.'s HeartSine Technologies issued a global correction of its Samaritan 300/300P public access defibrillators because some of the devices may not work right due to battery defects. Item

> Rapid Pathogen Screening used technology designed to detect explosives to develop a rapid test for conjunctivitis, or pink eye. Story

> Researchers believe they've developed an electronic "nose," used to detect molecules in a patient's breath, to diagnose obstructive sleep apnea. Details are published in the European Respiratory Journal. Release

Biotech News

 @FierceBiotech: From Swedish bioinformatics group grabs $840K to fuel growth, report says. More | Follow @FierceBiotech

 @JohnCFierce: Signs of life? Top 10 biotech IPOs. Special Report | Follow @JohnCFierce

 @RyanMFierce: GSK's SROne leads $35M round for Thrasos Therapeutics for PhII study of kidney injury treatment. Release | Follow @RyanMFierce

> Ex-Geron chief spearheads bid to revive mothballed stem cell studies. News

> Shire chief prepares to hand over reins to hand-picked successor. Story

> Profit plunge stokes M&A buzz as AstraZeneca chief vows to strike more deals. Report

Pharma News

@FiercePharma: Novartis puts off restart at Lincoln, Neb., plant... again. Fed-up CEO says no more predictions--Bloomberg. News | Follow @FiercePharma

> What's AZ's new CEO thinking? Let's parse his words. Story

> Gilenya, Afinitor among bright spots in flat Novartis quarter. Article

> Novartis plant delay, vaccine woes steal spotlight. More

Vaccines News

@AlisonBFierce: U. of Texas at Austin researchers got $6.5M from Dept. of Defense to develop new vaccines for emerging health threats. More | Follow @AlisonBFierce

> Italy bans Novartis influenza vaccines. News

> CDC green-lights GSK's meningitis vaccine for at-risk infants. Item

> HIV antibody development discovery advances vaccine search. Story

> EMA: 'Insufficient' link between narcolepsy and GSK flu vaccine. Report

> Novavax reports positive avian flu vaccine results. Article

Pharma Manufacturing News

> DSM snags another project to feed Australian biologics plant. More

> Novartis CEO defends manufacturing lapses. Article

> FDA group argues for helping poor countries beef up oversight. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.